You are using an outdated browser.
Upgrade your browser
to better experience this site.
2016 Annual Report
a profoundly different approach
a new modality in cancer care
the business of Novocure
the science of Novocure
mechanism of action
an effective anti-mitotic treatment
how electric field therapy kills cancer cells
application of therapy
Q&A with Ze'ev Bomzon
commercial execution
our commercial business
global active patient growth
TTFields in the solid tumor treatment paradigm
commercial footprint
Q&A with Tobias Weizel
pipeline development
addressing unmet medical needs
clinical milestones and next steps
Novocure clinical trial array placements
Novocure engineering
Q&A with Sharyn Ruperti
selected financials
financial highlights
consolidated statement of operations
Novocure leadership
downloads
downloads
Downloads
Format
Size
Novocure Proxy Statement
PDF
294 KB
Novocure 2016 10-K
PDF
1.7 MB
Novocure 2016 Annual Report
PDF
5.8 MB
downloads
